Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (60K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ramesh, N
Right arrow Articles by Osborne, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramesh, N
Right arrow Articles by Osborne, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 2697-2700

Footnote

High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site

High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site N. Ramesh , Seung-Taik Kim + , Ming Q. Wei , Mehraneh Khalighi and William R. A. Osborne*

Department of Pediatrics, University of Washington School of Medicine, Seattle , WA 98195, USA

Received April 2, 1996; Revised and Accepted June 3, 1996

ABSTRACT

Bicistronic retroviral vectors were constructed containing the foot-and-mouth disease virus (FMDV) internal ribosome entry site (IRES) followed by the coding region of [beta]-galactosidase ( [beta]-gal) or therapeutic genes, with the selectable neomycin phosphotransferase gene under the control of the viral long terminal repeat (LTR) promoter. LNFX, a vector with a multiple cloning site 3' to foot-and-mouth disease virus IRES, was used to construct vectors encoding rat erythropoietin (EP), rat granulocyte colony-stimulating factor (G-CSF), human adenosine deaminase (ADA) and [beta]-gal. In transduced primary rat vascular smooth muscle cells the cytokines were expressed at high levels, similar to those obtained from vectors employing the viral LTR promoter. LNFZ, a vector encoding [beta]-gal, had a 10-fold increase in titer over that of LNPoZ, a comparable vector containing the poliovirus (Po) internal ribosome entry site. Primary canine vascular smooth muscle cells infected with LNFZ and LNPoZ expressed similar activities of [beta] -gal and neomycin phosphotransferase (NPT). Overall, these vectors had titers between 106 and 2*107 c.f.u./ml, indicating that foot-and-mouth disease virus IRES provides high-titer bicistronic vectors with high-level two gene expression.

INTRODUCTION

Eukaryotic protein synthesis begins with the binding of initiation factors and the 40S ribosomal subunit to the 5'-capped structure at the 5' terminus of the mRNA, followed by the scanning of this complex and translation initiation at the most proximal AUG codon in a favorable context ( 1 ). In contrast, picornavirus RNAs are not capped and the translation initiation depends on direct binding of initiation complexes to the internal ribosomal entry site (IRES) within the 5' non-translated region ( 2 - 8 ). Based on their IRES sequence the picornaviruses can be divided into three groups: entero- and rhinoviruses, cardio- and aphthoviruses, and hepatitis A virus ( 9 , 10 ). Translation studies in a cell-free system showed IRES from the three groups responded differently, suggesting that the functional requirements for efficient IRES activity vary widely ( 11 ).

Retroviral vectors may be designed using these IRES to express multiple proteins from a single mRNA ( 12 - 14 ). We have shown the stable expression of both genes in bicistronic mRNAs transcribed from retroviral vectors in which encephalomyocarditis virus (EMCV) or poliovirus (Po) IRES were inserted between two cDNA coding regions ( 12 ). Foot-and-mouth disease virus (FMDV) is an aphthovirus of the picornavirus family and contains an IRES of ~480 bp ( 15 , 16 ), smaller than the 730 bp of the IRES of EMCV or Po ( 4 , 6 , 12 ). In this study we tested the ability of retroviral vectors containing FMDV IRES to provide high-titer and high-level bicistronic gene expression in transduced primary cells.

MATERIALS AND METHODS

Cell culture

PE 501 ecotropic and PA317 amphotropic packaging cells ( 17 ) and rat and dog vascular smooth muscle cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. Canine vascular smooth muscle cells were obtained from peripheral veins by enzymatic digestion as described for rat vascular tissue ( 18 ).

Retroviral vector construction

Scale drawings of the vectors with their best titers are shown in Figure 1 . Vector names are based on the order of genetic elements within the construct. Abbreviations and symbols are: LTR, retroviral long terminal repeat; S, simian virus 40 early promoter and enhancer; Neo, bacterial neomycin phosphotransferase cDNA; F, FMDV 5' non-translated IRES; Po, poliovirus IRES; E, EMCV IRES; [beta]-gal, [beta]-galactosidase cDNA; A, human adenosine deaminase cDNA; rEP, rat erythropoietin cDNA; rG, rat granulocyte colony stimulating factor cDNA. LNFZ vector construction: Sac I fragment of FMDV IRES ( 16 ) from pBIR (plasmid kindly provided by Dr E. Martinez-Salas, Madrid) was inserted into the Sac I site of pGEM-1. Po IRES from LNPoZ ( 12 ) was removed by Bst BI and Avr II digestion and was replaced by Acc I and Eco RI fragment of FMDV IRES after gap filling. LNFX was made by inserting the FMDV fragment from LNFZ in place of the SV40 promoter in the vector LNSX ( 17 ). The Sac I fragment from LNFX was cloned into pUC19 Sac I site, cut out with Sma I and Eco RI and cloned into pBSK in the same sites to make pBSK-F, which was then cut with Bam HI and Cla I and used to replace SV40 in LNSX. LNFrEP was obtained by inserting rat Epo cDNA [kindly provided by Drs Boissel and Bunn ( 19 )] into pBSK-F and inserting the FrEP fragment in place of SV40 in LNSX. LNFA was constructed by cloning the Cla I fragment of LNCA ( 20 ) encoding ADA cDNA into the Cla I site of LNFX. Amphotropic retroviral vectors were produced by shuttle packaging using PE501 and PA317 packaging cells ( 17 ). Briefly, plasmids were introduced into PE501 cells by calcium phosphate-mediated transfection, virus harvested 2 days later and used to infect PA317 cells. Clonal cell lines were isolated following selection in 1 mg/ml G418 and ~10 infected clones for each vector were screened for high-titer virus production by assay of secreted virus on NIH 3T3 TK - cells. Target cells were exposed to virus overnight, split 1 to 10 and drug resistant colonies counted after 5 days culture. Producer clones that contained single unrearranged proviruses by Southern analysis ( 21 ) were chosen for study.


Figure 1 . Vector names are based on the order of genetic elements within the construct. Abbreviations and symbols are: LTR, retroviral long terminal repeat; Neo, bacterial neomycin phosphotransferase cDNA; F, foot-and-mouth disease virus 5' non-translated IRES; Po, poliovirus IRES; E, encephalomyocarditis virus IRES; S, simian virus 40 early promoter and enhancer; [beta]-gal, [beta]-galactosidase cDNA; rG, rat G-CSF cDNA; rEP, rat EPO cDNA; ADA, human adenosine deaminase cDNA; viral titers are c.f.u./ml.

Enzyme activities

Activities of [beta]-gal in cell extracts were determined by spectrophotometric assay using 14 mM o-nitrophenyl [beta]-o-galactopyranoside as a substrate in 0.3 M sodium phosphate pH 7.0 ( 22 ). Neomycin phosphotransferase activities were measured by [[gamma]- 32 P]ATP phosphate transfer to neomycin ( 23 ).

Cytokine assays

Rat erythropoietin was determined by measuring proliferation of HCD 57, a murine cell line responsive to this cytokine ( 18 , 24 ) and rat G-CSF was assayed by proliferation of NSF-60, a murine cell line responsive to G-CSF ( 25 ). Recombinant human cytokines, kindly supplied by Amgen, were used to construct standard curves.

RESULTS

Virus production

Amphotropic helper-free virus was made from PA317 packaging cells, and G418 resistant clones that contained unrearranged proviruses were chosen for further study (data not shown). The five highest titers obtained from each new construct showed a reasonably tight range, and for all vectors the best two or three titers were comparable (Table 1 ). We compared LNFZ with LNPoZ, a similar vector that contains an IRES from poliovirus ( 12 ). For LNFZ-PA317 packaging cells the best viral titer was 10 6 c.f.u./ml whereas for LNPoZ-PA317 packaging cells a viral titer of 10 5 c.f.u./ml was achieved (Fig. 1 ). The titer of LNFA was ~3-fold greater than LAEN ( 12 ), a similar vector containing EMCV IRES (Fig. 1 ). Overall, the highest virus titers of the FMDV-constructs encoding therapeutic genes were in the range of 9 * 10 6 to 2 * 10 7 c.f.u./ml (Table 1 ), which are equivalent to or higher than the highset titers from LrGSN and LrEPSN, similar two gene vectors employing internal promoters (Fig. 1 ).

Table 1 . Titers of PA317 packaging cell clones
Virus titer(c.f.u./ml)

LNFX

LNFZ

LNFrEP

LNFrG

LNFA

3 * 10 6

1 * 10 6

2 * 10 7

9 * 10 6

1 * 10 7

1 * 10 6

7 * 10 5

1 * 10 7

8 * 10 6

1 * 10 7

1 * 10 6

7 * 10 5

1 * 10 7

5 * 10 6

3 * 10 6

3 * 10 5

5 * 10 5

6 * 10 6

4 * 10 6

3 * 10 6

1 * 10 5

5 * 10 5

6 * 10 6

3 * 10 6

2 * 10 6

Analysis of enzyme activities in transduced primary cells

Quantification of vector encoded protein expression obtained from extracts of packaging cells does not provide an accurate measure of transduced primary cell expression. Therefore, primary canine smooth muscle cells were transduced, selected in G418 and assayed for [beta]-gal ( 22 ) and neo activity ( 23 ). Extracts from LNFZ and LNPoZ transduced vascular smooth muscle cells showed similar [beta]-gal and neo activities (Table 2 ). X-gal staining for [beta]-gal activity showed uniform staining with both the vectors (data not shown).

Table 2 Enzyme activities in transduced canine vascular smooth muscle cells
Virus

Level of enzyme a

[beta]-gal

NPT

None

<0.1

<0.1

LNFZ

2.4

25.9

LNPoZ

2.6

31.9

a [beta]-galactosidase units are expressed as [mu]mol/min/mg protein. NPT units are c.p.m. * 10 -3 /h/[mu]g protein.

Erythropoietin and granulocyte colony-stimulating factor expression

Primary rat vascular smooth muscle cells were infected with vectors encoding either rat Epo cDNA or rat G-CSF cDNA, selected in G418, and assayed for the relevant cytokines. We compared the cytokine expression of bicistronic two gene vectors using foot-and-mouth disease virus IRES (LNFrG and LNFrEP) with conventional two gene vectors employing an internal SV40 viral promoter (LrGSN and LrEPSN) (Table 3 ). The vectors encoding erythropoietin produced equivalent activities in smooth muscle cells from both the LTR promoter in LrEPSN, and the bicistronic IRES construct in LNFrEP. However, neomycin phosphotransferase synthesis was not the same from these constructs, with the retroviral LTR promoter in LNFrEP producing greater enzyme expression than the SV40 early promoter in LrEPSN (Table 3 ), in agreement with previous studies ( 12 ). Secretion of G-CSF was greater from the LTR promoter in LrGSN than that observed from the bicistronic LNFrG construct, unlike the equivalent levels of erythropoietin obtained from LrEPSN and LNFrEP.

Table 3 . Cytokine expression in transduced rat vascular smooth muscle cells

Gene expression a

Virus

Cytokine

NPT

LNFrEP

6.8

45.6

LrEPSN

6.7

8.7

LNFrG

0.1

ND

LrGSN

0.4

ND

a NPT units same as in Table 2. Epo measured as mU/24 h/10 5 cells; G-CSF units are ng/24 h/10 6 cells. ND, not done.

DISCUSSION

These studies have shown that the IRES from foot-and-mouth disease virus allows the production of two-gene vectors that provide both high titer and high level gene expression. The FMDV-containing vectors, encoding erythropoietin or G-CSF, both showed higher titers than the two-gene vectors employing conventional internal promoters that were used as controls. However, the two constructs we tested for erythropoietin synthesis exhibited similar activities in primary smooth muscle cells, whereas the comparable vectors we tested for G-CSF secretion gave higher levels from the LTR promoter in comparison with the bicistronic construct. The unpredictability of vector performance has been recognized ( 26 ), and suggests that vectors need to be constructed and tested in desired cell types to determine their optimal activity.

The vector LNFZ encoding [beta]-gal and containing FMDV IRES produced a 10-fold increase in viral titer over LNPoZ, the virus containing Po IRES. This increase in titer may indicate a higher efficiency of packaging in viruses containing FMDV IRES. The relatively lower titer of vectors encoding bacterial [beta]-gal (10 5 -10 6 c.f.u./ml) probably indicates RNA instability or a secondary structure not optimal for efficient virus packaging. However, in a study of retroviral vectors expressing human purine nucleoside phosphorylase (PN) we observed that the presence or absence of an EMCV IRES did not produce a major change in viral titer ( 12 ). In this study three viruses expressing human purine nucleoside phosphorylase, LPNSN-2, LNEPN and LNPN had titers ranging from 3 * 10 6 to 5 * 10 6 c.f.u./ml. LPNSN-2 contains SV40 internal promoter, LNEPN contains EMCV IRES, and LNPN was a control virus lacking both an internal promoter and an IRES.

Our data are in agreement with the recent studies of Borman et al . ( 11 ) that showed not only a wide range in the efficiency of internal initiation, but also a higher efficiency from cardio- and aphthovirus IRES over poliovirus IRES. On the basis of IRES-initiated translation in vitro , the picornaviruses can be classified in a similar manner to their sequence homologies, and that while all entry sites can direct internal ribosome entry, the functional requirements for efficient IRES activity vary quite widely.

Our results with cDNA inserts of ~1 kb (rat granulocyte-colony stimulating factor, rat erythropoietin and human adenosine deaminase) showed vector titers of ~10 7 c.f.u./ml. The five highest titers obtained for each constuct showed a relatively close range, and at least two equivalently high titers were observed for each, indicating that FMDV IRES viruses provide routinely higher titers than vectors encoding Po or EMCV IRES ( 12 ). Increases in viral titer in constructs containing FMDV IRES was observed even when using the 3 kb [beta]-gal cDNA insert, suggesting that this IRES may have a general application in the construction of high titer retroviruses. As [beta]-gal expressing vectors are widely used, not only in gene therapy applications but also in developmental studies, LNFZ offers a distinct improvement over current viruses. Two gene retroviral vectors containing picornavirus internal ribosome entry sites possess the distinct advantage that selection for expression of one of the genes ensures expression of the other, which is not the situation when other strategies are used ( 8 , 12 , 13 ). Finally, the low sequence homology between the FMDV IRES and the EMCV or Po IRES together with its smaller size should make this IRES segment an ideal candidate in the construction of useful tricistronic retroviral vectors.

ACKNOWLEDGEMENTS

We thank Dr E. Martinez-Salas for the plasmid pBIR encoding foot-and-mouth disease virus IRES. We thank Stella Lau for expert technical assistance. This work was supported by grants DK 43727 and DK 38531 from the NIH.

REFERENCES

1 Kozak,M. (1989) J. Cell Biol., 108, 229-241. MEDLINE Abstract

2 Jang,S.K., Krausslich,H.-G., Nicklin,M.J.H., Duke,G.M., Palmenberg,S.C. and Wimmer,E. (1988) J. Virol., 62, 2636-2643. MEDLINE Abstract

3 Pelletier,J., Kaplan,G., Racaniello,V.R. and Sonenberg,N. (1988) Mol. Cell Biol., 8, 1103-1112. MEDLINE Abstract

4 Sonenberg,N. (1990) Curr. Top. Microbiol. Immunl., 161, 23-37.

5 Trono,D., Pelletier,J., Sonenberg,N. and Baltimore,D. (1988) Science, 241, 445-448. MEDLINE Abstract

6 Jang,S.K. and Wimmer,E. (1990) Genes Dev., 4, 1560-1572. MEDLINE Abstract

7 Oh,S.-Y. and Sarnow,P. (1993) Curr. Opin. Genet. Dev., 3, 295-300. MEDLINE Abstract

8 Mountford,P.S. and Smith,A.G. (1995) Trends Genet., 5, 179-184.

9 Pilipenko, E.V., Blinov,V.M., Romanova,L.I., Sinyakov,A.N., Maslova,S.V. and Agol,V.I. (1989) Virology, 168, 201-209. MEDLINE Abstract

10 Pilipenko,E.V., Blinov,V.M., Romanova,L.I., Sinyakov,A.N., Maslova,S.V. and Agol,V.I. (1989) Nucleic Acids Res., 17, 5701-5711. MEDLINE Abstract

11 Borman,A.M., Bailly,J.-L., Girard,M. and Kean,L.M. (1995) Nucleic Acids Res., 23, 3656-3663. MEDLINE Abstract

12 Adam,M.A., Ramesh,N., Miller,A.D. and Osborne,W.R.A. (1991) J. Virol. 65, 4985-4990. MEDLINE Abstract

13 Ghattas,I.R., Sanes,J.R. and Majors,J.E. (1991) Mol. Cell Biol., 11, 5848-5859. MEDLINE Abstract

14 Morgan,R.A., Couture,L., Elroy-Stein,O., Ragheb,J., Moss,B. and Anderson,W.A. (1992) Nucleic Acids Res., 20, 1293-1299. MEDLINE Abstract

15 Kuhn,R., Luz,N. and Beck,E. (1990) J. Virol., 64, 4625-4631. MEDLINE Abstract

16 Martinez-Salas,E., Saiz,J.C., Davila,M., Belsham,G.J. and Domingo,E. (1993) J. Virol., 67, 3748-3755.

17 Miller,A.D. and Rosman,G.J. (1989) BioTechniques, 7, 980-990. MEDLINE Abstract

18 Osborne,W.R.A., Ramesh,N., Lau,S., Clowes,M.M., Dale,D.C. and Clowes,A.W. (1995) Proc. Natl. Acad. Sci. USA, 92, 8055-8058. MEDLINE Abstract

19 Wen,D., Poissel,J.-P.R., Tracy,T.E., Gruninger,R.H., Mulcahy,L.S., Czelusniak,J., Goodman,M. and Bunn,H.F. (1993) Blood, 82, 1507-1516.

20 Hock,R.A., Miller,A.D. and Osborne,W.R.A. (1989) Blood, 74, 876-881. MEDLINE Abstract

21 Osborne,W.R.A. and Miller,A.D. (1988) Proc. Natl. Acad. Sci. USA, 85, 6851-6855. MEDLINE Abstract

22 Lim,K. and Chae,C.-B. (1989) BioTechniques, 7, 576-579. MEDLINE Abstract

23 Ramesh,N. and Osborne,W.R.A. (1991) Anal. Biochem., 193, 316-318. MEDLINE Abstract

24 Spivak,J.L., Pham,T., Isaacs,M. and Hankins,W.D. (1991) Blood, 77, 1228-1233. MEDLINE Abstract

25 Dale,D.C., Lau,S., Nash,R., Boone,T. and Osborne,W.R. (1992) J. Infect. Dis., 165, 689-694. MEDLINE Abstract

26 Adam,M.A., Osborne,W.R.A. and Miller,A.D. (1995) Hum. Gene Ther., 6, 1169-1176. MEDLINE Abstract


Return

* To whom correspondence should be addressed + Present address: Department of Internal Medicine, College of Medicine, Chungbuk, Cheongju, Korea
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
O. Yanay, S. C. Barry, L. J. Katen, M. Brzezinski, L. Y. Flint, J. Christensen, D. Liggitt, D. C. Dale, and W. R. A. Osborne
Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF delivery
Blood, September 15, 2003; 102(6): 2046 - 2052.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Hennecke, M. Kwissa, K. Metzger, A. Oumard, A. Kroger, R. Schirmbeck, J. Reimann, and H. Hauser
Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs
Nucleic Acids Res., August 15, 2001; 29(16): 3327 - 3334.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. D. Allen
Myocardial protection: is there a role for gene therapy?
Ann. Thorac. Surg., November 1, 1999; 68(5): 1924 - 1928.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
J. LOSMAN, X.P. CHEN, H. JIANG, P.-Y. PAN, M. KASHIWADA, C. GIALLOURAKIS, S. COWAN, K. FOLTENYI, and P. ROTHMAN
IL-4 Signaling Is Regulated through the Recruitment of Phosphatases, Kinases, and SOCS Proteins to the Receptor Complex
Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 405 - 416.
[Abstract] [PDF]


Home page
BloodHome page
D. V. Lejnieks, N. Ramesh, S. Lau, and W. R.A. Osborne
Stomach Implant for Long-Term Erythropoietin Expression in Rats
Blood, August 1, 1998; 92(3): 888 - 893.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (60K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ramesh, N
Right arrow Articles by Osborne, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramesh, N
Right arrow Articles by Osborne, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?